These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37069998)

  • 1. Identification of Glomerular and Plasma Apolipoprotein M as Novel Biomarkers in Glomerular Disease.
    Drexler Y; Molina J; Elfassy T; Ma R; Christoffersen C; Kurano M; Yatomi Y; Mariani LH; Contreras G; Merscher S; Fornoni A
    Kidney Int Rep; 2023 Apr; 8(4):884-897. PubMed ID: 37069998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of Glomerular Structural Lesions: Associations With Clinical Outcomes and Transcriptomic Profiles in Nephrotic Syndrome.
    Hodgin JB; Mariani LH; Zee J; Liu Q; Smith AR; Eddy S; Hartman J; Hamidi H; Gaut JP; Palmer MB; Nast CC; Chang A; Hewitt S; Gillespie BW; Kretzler M; Holzman LB; Barisoni L;
    Am J Kidney Dis; 2022 Jun; 79(6):807-819.e1. PubMed ID: 34864148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing Kidney Health Outcomes in Children, Adolescents, and Adults With Focal Segmental Glomerulosclerosis.
    Gipson DS; Troost JP; Spino C; Attalla S; Tarnoff J; Massengill S; Lafayette R; Vega-Warner V; Adler S; Gipson P; Elliott M; Kaskel F; Fermin D; Moxey-Mims M; Fine RN; Brown EJ; Reidy K; Tuttle K; Gibson K; Lemley KV; Greenbaum LA; Atkinson MA; Hingorani S; Srivastava T; Sethna CB; Meyers K; Tran C; Dell KM; Wang CS; Yee JL; Sampson MG; Gbadegesin R; Lin JJ; Brady T; Rheault M; Trachtman H
    JAMA Netw Open; 2022 Aug; 5(8):e2228701. PubMed ID: 36006643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine 1-phosphate and its carrier apolipoprotein M in human sepsis and in Escherichia coli sepsis in baboons.
    Frej C; Linder A; Happonen KE; Taylor FB; Lupu F; Dahlbäck B
    J Cell Mol Med; 2016 Jun; 20(6):1170-81. PubMed ID: 26990127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
    Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A
    Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary Epidermal Growth Factor as a Marker of Disease Progression in Children With Nephrotic Syndrome.
    Gipson DS; Trachtman H; Waldo A; Gibson KL; Eddy S; Dell KM; Srivastava T; Lemley KV; Greenbaum LA; Hingorani S; Meyers KE; Kaskel FJ; Reidy KJ; Sethna CB; Tran CL; Wang CS; Tuttle KR; Oh G; Neu AM; Brown E; Lin JJ; Yee JL; Roth TM; Troost JP; Gillespie BW; Sampson MG; Kretzler M; Ju W
    Kidney Int Rep; 2020 Apr; 5(4):414-425. PubMed ID: 32280839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate.
    Sutter I; Park R; Othman A; Rohrer L; Hornemann T; Stoffel M; Devuyst O; von Eckardstein A
    J Lipid Res; 2014 Aug; 55(8):1730-7. PubMed ID: 24950692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
    Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
    J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of sphingosine-1-phosphate and apolipoprotein M levels in the plasma, liver and kidneys in streptozotocin-induced diabetic mice.
    Nojiri T; Kurano M; Tokuhara Y; Ohkubo S; Hara M; Ikeda H; Tsukamoto K; Yatomi Y
    J Diabetes Investig; 2014 Nov; 5(6):639-48. PubMed ID: 25422763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein M Protects Against Lipopolysaccharide-Induced Acute Lung Injury via Sphingosine-1-Phosphate Signaling.
    Zhu B; Luo GH; Feng YH; Yu MM; Zhang J; Wei J; Yang C; Xu N; Zhang XY
    Inflammation; 2018 Mar; 41(2):643-653. PubMed ID: 29260347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein M supports S1P production and conservation and mediates prolonged Akt activation via S1PR1 and S1PR3.
    Kiyozuka K; Zhao X; Konishi A; Minamishima YA; Obinata H
    J Biochem; 2023 Jul; 174(3):253-266. PubMed ID: 37098187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of apolipoprotein M in uremic atherosclerosis.
    Bosteen MH; Madsen Svarrer EM; Bisgaard LS; Martinussen T; Madsen M; Nielsen LB; Christoffersen C; Pedersen TX
    Atherosclerosis; 2017 Oct; 265():93-101. PubMed ID: 28866363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein M/sphingosine 1-phosphate protects against diabetic nephropathy.
    Kurano M; Tsukamoto K; Shimizu T; Hara M; Yatomi Y
    Transl Res; 2023 Aug; 258():16-34. PubMed ID: 36805561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus.
    Liu M; Frej C; Langefeld CD; Divers J; Bowden DW; Carr JJ; Gebre AK; Xu J; Larsson B; Dahlbäck B; Freedman BI; Parks JS
    J Lipid Res; 2019 Aug; 60(8):1425-1431. PubMed ID: 31133557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.
    Liu M; Allegood J; Zhu X; Seo J; Gebre AK; Boudyguina E; Cheng D; Chuang CC; Shelness GS; Spiegel S; Parks JS
    J Biol Chem; 2015 Mar; 290(12):7861-70. PubMed ID: 25627684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. APOL1-associated glomerular disease among African-American children: a collaboration of the Chronic Kidney Disease in Children (CKiD) and Nephrotic Syndrome Study Network (NEPTUNE) cohorts.
    Ng DK; Robertson CC; Woroniecki RP; Limou S; Gillies CE; Reidy KJ; Winkler CA; Hingorani S; Gibson KL; Hjorten R; Sethna CB; Kopp JB; Moxey-Mims M; Furth SL; Warady BA; Kretzler M; Sedor JR; Kaskel FJ; Sampson MG
    Nephrol Dial Transplant; 2017 Jun; 32(6):983-990. PubMed ID: 27190333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the metabolism of apolipoprotein M and sphingosine 1-phosphate by hepatic PPARγ activity.
    Kurano M; Ikeda H; Iso-O N; Hara M; Tsukamoto K; Yatomi Y
    Biochem J; 2018 Jun; 475(12):2009-2024. PubMed ID: 29712716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interstitial fibrosis scored on whole-slide digital imaging of kidney biopsies is a predictor of outcome in proteinuric glomerulopathies.
    Mariani LH; Martini S; Barisoni L; Canetta PA; Troost JP; Hodgin JB; Palmer M; Rosenberg AZ; Lemley KV; Chien HP; Zee J; Smith A; Appel GB; Trachtman H; Hewitt SM; Kretzler M; Bagnasco SM
    Nephrol Dial Transplant; 2018 Feb; 33(2):310-318. PubMed ID: 28339906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete Remission in the Nephrotic Syndrome Study Network.
    Gipson DS; Troost JP; Lafayette RA; Hladunewich MA; Trachtman H; Gadegbeku CA; Sedor JR; Holzman LB; Moxey-Mims MM; Perumal K; Kaskel FJ; Nelson PJ; Tuttle KR; Bagnasco SM; Hogan MC; Dell KM; Appel GB; Lieske JC; Ilori TO; Sethna CB; Fervenza FC; Hogan SL; Nachman PH; Rosenberg AZ; Greenbaum LA; Meyers KE; Hewitt SM; Choi MJ; Kopp JB; Zhdanova O; Hodgin JB; Johnstone DB; Adler SG; Avila-Casado C; Neu AM; Hingorani SR; Lemley KV; Nast CC; Brady TM; Barisoni-Thomas L; Fornoni A; Jennette JC; Cattran DC; Palmer MB; Gibson KL; Reich HN; Mokrzycki MH; Sambandam KK; Zilleruelo GE; Licht C; Sampson MG; Song P; Mariani LH; Kretzler M
    Clin J Am Soc Nephrol; 2016 Jan; 11(1):81-9. PubMed ID: 26656320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein M induces inhibition of inflammatory responses via the S1PR1 and DHCR24 pathways.
    Wang M; Luo GH; Liu H; Zhang YP; Wang B; Di DM; Zhan XH; Yu Y; Yao S; Zhang XY; Xu N
    Mol Med Rep; 2019 Feb; 19(2):1272-1283. PubMed ID: 30569161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.